Mr. Grothman (for himself, Ms. Bonamici, Mr. Bilirakis, Mr. Higgins of New York, Mr. Fitzpatrick, Mr. Morelle, and Ms. Matsui) introduced the following bill; which was referred to the Committee on Education and the Workforce
To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Cancer Drug Parity Act of 2023. H.R. 6301. 118th
Cong., 1st
sess., Introduced in House November 8, 2023. https://www.govinfo.gov/app/details/BILLS-118hr6301ih.
APA
Congress, House of Representatives (2023, November 8). Cancer Drug Parity Act of 2023 (H.R. 6301 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-118hr6301ih.
MLA
United States, Congress, House of Representatives. Cancer Drug Parity Act of 2023. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-118hr6301ih. 118th Congress, H.R. 6301, Introduced in House 8 Nov. 2023.
Bluebook
H.R.6301 - 118th Congress (2023-2024): Cancer Drug Parity Act of 2023, H.R.6301, 118th Cong. (2023), https://www.govinfo.gov/app/details/BILLS-118hr6301ih.
